High-risk women are those with a pre-existing vertebral fracture, recent fracture on treatment or continuing low BMD (T score ≤ −2.5). In low-risk patients, treatment could be stopped after five years, but the BMD should be re-measured one year after treatment cessation. Measuring bone turnover markers after three months is also useful: examples of suitable …
Continue reading “How long should you continue bisphosphonates in women with osteoporosis?”